High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management
- 7 March 2011
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 74 (4) , 438-444
Abstract
The prevalence of subclinical hypercortisolism (SH) in unilateral incidentalomas (UI) has been extensively studied; however, patients with bilateral incidentalomas (BI) have not been thoroughly investigated. We therefore aimed to describe the characteristics of patients with BI compared to their unilateral counterparts. The surgical outcome in a small number of patients is reported. Observational retrospective study in a single secondary/tertiary centre. One hundred and seventy-two patients with adrenal incidentalomas (41 with BI). Morning cortisol (F), ACTH, dehydroepiandrosterone sulphate (DHEA-S), midnight F, 24-h urine collection for cortisol (UFC), low-dose dexamethasone suppression test (LDDST), fasting glucose, insulin, and oral glucose tolerance test (OGTT). Primarily, SH was defined as F-post-LDDST>70 nmol/l and one more abnormality; several diverse cut-offs were also examined. No difference was noted in age, body mass index, or prevalence of diabetes and impaired glucose tolerance between patients with UI and those with BI. Patients with BI had higher F-post-LDDST (119·3 ± 112·8 vs 54·3 ± 71·5 nmol/l, P<0·001) and lower DHEA-S (1·6 ± 1·5 vs 2·5 ± 2·3 μmol/l, P=0·003) but similar UFC, ACTH and midnight F levels, compared to UI. SH was significantly more prevalent in BI (41·5%vs 12·2%, P<0·001). Fourteen patients were operated on; four underwent bilateral interventions. In 10 patients, unilateral adrenalectomy on the side of the largest lesion resulted in significant improvement in F-post-LDDST (P=0·008) and a decrease in midnight F (P=0·015) levels. Subclinical hypercortisolism is significantly more prevalent in bilateral incidentaloma patients, posing great dilemmas for its optimum management.Keywords
This publication has 33 references indexed in Scilit:
- Is Subclinical Cushing’s Syndrome an Entity or a Statistical Fallout from Diagnostic Testing? Consensus Surrounding the Diagnosis Is Required before Optimal Treatment Can Be DefinedThe Journal of Clinical Endocrinology & Metabolism, 2010
- Beneficial Metabolic Effects of Prompt Surgical Treatment in Patients with an Adrenal Incidentaloma Causing Biochemical HypercortisolismThe Journal of Clinical Endocrinology & Metabolism, 2010
- Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized StudyAnnals of Surgery, 2009
- Overrepresentation of the N363S Variant of the Glucocorticoid Receptor Gene in Patients with Bilateral Adrenal IncidentalomasThe Journal of Clinical Endocrinology & Metabolism, 2006
- Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implicationsJournal of Endocrinological Investigation, 2006
- Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgeryEuropean Journal of Endocrinology, 2003
- The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary TumorsThe Journal of Clinical Endocrinology & Metabolism, 2002
- Subclinical Cushing's Syndrome in Patients with Adrenal Incidentaloma: Clinical and Biochemical FeaturesThe Journal of Clinical Endocrinology & Metabolism, 2000
- Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic CorrelatesThe Journal of Clinical Endocrinology & Metabolism, 1998
- Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)The Journal of Clinical Endocrinology & Metabolism, 1994